FSTX logo

F-star Therapeutics (FSTX) Cash From Investing

Annual CFI

-$643.00 K
-$14.69 M-104.58%

December 31, 2021


Summary


Performance

FSTX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFSTXcash flowmetrics:

Quarterly CFI

$1000.00
+$357.00 K+100.28%

September 30, 2022


Summary


Performance

FSTX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFSTXcash flowmetrics:

TTM CFI

-$355.00 K
+$1000.00+0.28%

September 30, 2022


Summary


Performance

FSTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherFSTXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

FSTX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-104.6%+100.0%-102.6%
3 y3 years-112.0%+101.6%-472.6%
5 y5 years-112.0%+101.6%-472.6%

FSTX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat lowat high<-9999.0%at high+81.1%
5 y5-year-104.6%at low-100.0%<-9999.0%-102.5%+81.1%
alltimeall time-104.6%at low-100.0%<-9999.0%-102.5%+81.1%

F-star Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2022
-
$1000.00(-100.3%)
-$355.00 K(-0.3%)
Jun 2022
-
-$356.00 K(<-9900.0%)
-$356.00 K(-9.0%)
Mar 2022
-
$0.00(0.0%)
-$391.00 K(-39.2%)
Dec 2021
-$643.00 K
$0.00(0.0%)
-$643.00 K(-104.8%)
Sep 2021
-
$0.00(-100.0%)
$13.46 M(-0.1%)
Jun 2021
-
-$391.00 K(+55.2%)
$13.47 M(-2.8%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$252.00 K(-101.8%)
$13.86 M(-1.4%)
Dec 2020
$14.05 M(+161.5%)
$14.10 M(>+9900.0%)
$14.05 M(<-9900.0%)
Sep 2020
-
$12.00 K(>+9900.0%)
-$50.00 K(-19.4%)
Jun 2020
-
$0.00(-100.0%)
-$62.00 K(0.0%)
Mar 2020
-
-$62.00 K
-$62.00 K
Dec 2019
$5.37 M
-
-

FAQ

  • What is F-star Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for F-star Therapeutics?
  • What is F-star Therapeutics annual CFI year-on-year change?
  • What is F-star Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for F-star Therapeutics?
  • What is F-star Therapeutics quarterly CFI year-on-year change?
  • What is F-star Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for F-star Therapeutics?
  • What is F-star Therapeutics TTM CFI year-on-year change?

What is F-star Therapeutics annual cash flow from investing activities?

The current annual CFI of FSTX is -$643.00 K

What is the all time high annual CFI for F-star Therapeutics?

F-star Therapeutics all-time high annual cash flow from investing activities is $14.05 M

What is F-star Therapeutics annual CFI year-on-year change?

Over the past year, FSTX annual cash flow from investing activities has changed by -$14.69 M (-104.58%)

What is F-star Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of FSTX is $1000.00

What is the all time high quarterly CFI for F-star Therapeutics?

F-star Therapeutics all-time high quarterly cash flow from investing activities is $14.10 M

What is F-star Therapeutics quarterly CFI year-on-year change?

Over the past year, FSTX quarterly cash flow from investing activities has changed by +$1000.00 (+100.00%)

What is F-star Therapeutics TTM cash flow from investing activities?

The current TTM CFI of FSTX is -$355.00 K

What is the all time high TTM CFI for F-star Therapeutics?

F-star Therapeutics all-time high TTM cash flow from investing activities is $14.05 M

What is F-star Therapeutics TTM CFI year-on-year change?

Over the past year, FSTX TTM cash flow from investing activities has changed by -$13.81 M (-102.64%)